Published in J Pediatr on August 01, 1983
Comparison of kinetic study of the photochemical changes of (ZZ)-bilirubin IX alpha bound to human serum albumin with that bound to rat serum albumin. Biochem J (1985) 0.81
In vitro and in vivo efficacy of new blue light emitting diode phototherapy compared to conventional halogen quartz phototherapy for neonatal jaundice. J Korean Med Sci (2005) 0.77
Data in support of effect of blue LED irradiation in human lymphoma cells. Data Brief (2016) 0.75
The effect of bilirubin photoisomers on unbound-bilirubin concentrations estimated by the peroxidase method. Biochem J (1986) 0.75
Bilirubin is an antioxidant of possible physiological importance. Science (1987) 11.26
The ready isomerization of bilirubin IX- in aqueous solution. Biochem J (1972) 2.50
The enzymatic formation of bilirubin. Ann N Y Acad Sci (1975) 2.34
Phytochrome chromophore biosynthesis. Treatment of tetrapyrrole-deficient Avena explants with natural and non-natural bilatrienes leads to formation of spectrally active holoproteins. J Biol Chem (1989) 2.01
The meso-reactivity of porphyrins and related compounds. VI. Oxidative cleavage of the haem system. The four isomeric biliverdins of the IX series. J Chem Soc Perkin 1 (1973) 1.92
Blue light and bilirubin excretion. Science (1980) 1.81
Configurational isomerization of bilirubin and the mechanism of jaundice phototherapy. Biochem Biophys Res Commun (1979) 1.76
Staphylococcal and streptococcal colonization of the newborn infant: effect of antiseptic cord care. Am J Dis Child (1977) 1.70
Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis. J Antimicrob Chemother (1983) 1.56
The role of singlet oxygen in bilirubin photo-oxidation. Biochem Biophys Res Commun (1971) 1.55
Photobilirubin: an early bilirubin photoproduct detected by absorbance difference spectroscopy. Proc Natl Acad Sci U S A (1979) 1.53
Diagnosis of gastritis caused by Helicobacter pylori in children by means of an ELISA. Rev Infect Dis (1991) 1.52
Photodynamic therapy of malignant tumours. Lancet (1972) 1.48
Preparation and properties of crystalline biliverdin IX alpha. Simple methods for preparing isomerically homogeneous biliverdin and [14C[biliverdin by using 2,3-dichloro-5,6-dicyanobenzoquinone. Biochem J (1980) 1.29
Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest (1995) 1.29
Turning green to gold. Nat Struct Biol (2001) 1.27
Phototherapy for neonatal hyperbilirubinemia: efficacy, mechanism and toxicity. Adv Pediatr (1980) 1.17
Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. Free Radic Biol Med (1995) 1.14
Degradation of hepatic haem to porphyrins and oxophlorins in rats treated with 2-allyl-2-isopropylacetamide. Biochem Soc Trans (1976) 1.14
Metronidazole bioassay. Antimicrob Agents Chemother (1976) 1.11
Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol (1990) 1.11
'Like a shrivelled blood orange'--bilirubin, jaundice, and phototherapy. Pediatrics (1985) 1.10
Mutagenicity of metronidazole: activation by mammalian liver microsomes. Biochem Biophys Res Commun (1975) 1.08
Jaundice phototherapy: micro flow-cell photometry reveals rapid biliary response of Gunn rats to light. Science (1978) 1.06
Thermal and photochemical reactions of bilirubin IX-alpha. Ann N Y Acad Sci (1975) 1.05
Current therapy for Crigler-Najjar syndrome type 1: report of a world registry. Hepatology (1996) 1.03
Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J (1996) 1.02
Phototherapy of neonatal jaundice. Biochem Soc Trans (1976) 1.00
[New synthesis and 14 C-labelling of bilirubin-IXalpha]. Justus Liebigs Ann Chem (1972) 0.97
Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives. Antimicrob Agents Chemother (1982) 0.96
Photochemotherapy of glioma cells by visible light and hematoporphyrin. Cancer Res (1975) 0.95
Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. J Clin Invest (1984) 0.93
A cautionary note the use of nitroreductase-deficient strains of Salmonella typhimurium for the detection of nitroarenes as mutagens in complex mixtures including diesel exhausts. Mutat Res (1981) 0.93
Physical properties of nucleoprotein cores from adenovirus type 5. Nucleic Acids Res (1977) 0.92
Relative importance of bacterial and mammalian nitroreductases for niridazole mutagenesis. Cancer Res (1980) 0.91
Disposition and irreversible plasma protein binding of tolmetin in humans. Clin Pharmacol Ther (1988) 0.91
On the acid dissociation constants of bilirubin and biliverdin. pKa values from 13C NMR spectroscopy. J Biol Chem (1996) 0.90
Mutagenicity of metronidazole: presence of several active metabolites in human urine. J Natl Cancer Inst (1976) 0.90
Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. Proc Natl Acad Sci U S A (1993) 0.88
Base substitution mutations induced in Salmonella strains by visible light (450 nm). Photochem Photobiol (1975) 0.87
The photodynamic modification of DNA by hematoporphyrin. Biochim Biophys Acta (1977) 0.87
In vitro studies of effects of light and riboflavin on DNA and HeLa cells. Pediatr Res (1975) 0.87
Evidence for singlet oxygen quenching by biliverdin IX-alpha dimethyl ester and its relevance to bilirubin photo-oxidation. Biochem Biophys Res Commun (1972) 0.87
Aqueous dissociation constants of bile pigments and sparingly soluble carboxylic acids by 13C NMR in aqueous dimethyl sulfoxide: effects of hydrogen bonding. J Lipid Res (1997) 0.87
Bilirubin photoisomerization in premature neonates under low- and high-dose phototherapy. Pediatrics (1985) 0.87
Effect of antiseptic cord care on bacterial colonization in the newborn infant. Chemotherapy (1980) 0.86
Mutagenicity and DNA-modifying activity: a comparison of two microbial assays. Mutat Res (1976) 0.86
Ionic effects on the structure of nucleoprotein cores from adenovirus. Biochim Biophys Acta (1985) 0.86
Evaluation of moxalactam. Clin Pharm (1983) 0.85
Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry. Drug Metab Dispos (1995) 0.85
Effect of spectral distribution on isomerization of bilirubin in vivo. J Pediatr (1985) 0.85
Reduction of biliverdin and placental transfer of bilirubin and biliverdin in the pregnant guinea pig. Biochem J (1981) 0.85
Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. Drug Metab Dispos (1991) 0.84
Quantum yields for laser photocyclization of bilirubin in the presence of human serum albumin. Dependence of quantum yield on excitation wavelength. Photochem Photobiol (1989) 0.84
Dissociation constants of water-insoluble carboxylic acids by 13C-NMR. pK(a)s of mesobiliverdin-XIII alpha and mesobilirubin-XIII alpha. Experientia (1996) 0.84
Activation of nitrofurantoin to a mutagen by rat liver nitroreductase. Biochem Pharmacol (1976) 0.84
Phototherapy for neonatal jaundice: in vitro comparison of light sources. Pediatr Res (1984) 0.84
Activation of a procarcinogen to a mutagen by cell-free extracts of anaerobic bacteria. Mutat Res (1977) 0.83
Campylobacter pylori: a new pathogen. Adv Pediatr Infect Dis (1990) 0.83
Photophysical studies of tin(IV)-protoporphyrin: potential phototoxicity of a chemotherapeutic agent proposed for the prevention of neonatal jaundice. Proc Natl Acad Sci U S A (1988) 0.83
Tin-protoporphyrin: a potent photosensitizer of bilirubin destruction. Photochem Photobiol (1985) 0.83
Calculated free bilirubin levels and neurotoxicity. J Perinatol (2009) 0.83
Determination of the relative detector response for unstable bilirubin photoproducts without isolation. J Chromatogr (1986) 0.82
Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J Clin Invest (1986) 0.82
Differences in bilirubin isomer composition in infants treated with green and white light phototherapy. J Pediatr (1986) 0.82
Structure and metabolism of natural and synthetic bilirubins. J Perinatol (2001) 0.82
Phototherapy for neonatal jaundice: in vivo clearance of bilirubin photoproducts. Pediatr Res (1985) 0.82
Mutagenicity of azathioprine. Cancer Res (1976) 0.81
Natural history of neonatal colonization with group B streptococci. Pediatrics (1977) 0.81
Clostridia as pathogens in neonatal necrotizing enterocolitis. J Pediatr (1979) 0.81
Mutagenicity and DNA-modifying activity of 2-nitropropane. Mutat Res (1982) 0.80
Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing. Clin Pharmacol Ther (1994) 0.80
A study of the photoinduced mutagenicity of methylene blue. Mutat Res (1977) 0.80
Phototherapy for neonatal jaundice. Photochem Photobiol (1988) 0.80
Absence of bacteremia in children after prophylaxis. Oral Surg Oral Med Oral Pathol (1971) 0.80
Wavelength dependence of the quantum yield for the structural isomerization of bilirubin. Photochem Photobiol (1987) 0.80
Heme catabolism in fish. Bile pigments in gallbladder bile of the electric torpedo, Torpedo californicus. Comp Biochem Physiol B (1982) 0.80
Primary peritonitis and the nephrotic syndrome. Am J Surg (1974) 0.79
Phototherapy: a new twist to bilirubin. J Pediatr (1981) 0.79
Wavelength-dependent quantum yield for Z----E isomerization of bilirubin complexed with human serum albumin. Photochem Photobiol (1992) 0.79
Effect of bacterial flora on staphylococcal colonisation of the newborn. J Clin Pathol (1978) 0.79
Effect of esterase inhibition on the disposition of zomepirac glucuronide and its covalent binding to plasma proteins in the guinea pig. J Pharmacol Exp Ther (1990) 0.79
The cephalosporin antibiotics. Pediatr Clin North Am (1983) 0.79
An evaluation of the prophage lambda induction (inductest) for the detection of potential carcinogens. Mutat Res (1978) 0.79
Light-induced mutagenicity of neutral red (3-amino-7-dimethylamino-2-methylphenazine hydrochloride). Cancer Res (1977) 0.79
Actinobacillus actinomycetemcomitans endophthalmitis with subacute endocarditis. Ann Ophthalmol (1984) 0.79
A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia. Commentary. J Pediatr (1979) 0.78
Inhibition of DNA synthesis accompanied by stimulation of protein synthesis in novobiocin-treated developing sea urchins. Mutat Res (1982) 0.78
Development of meningitis during therapy with cefamandole. Pediatrics (1981) 0.78
Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro. Pharm Res (1990) 0.78
Salicylate hepatitis: a complication of the treatment of Kawasaki's disease. Am J Hosp Pharm (1981) 0.78
Genetic effects of providone-iodine. J Pharm Sci (1975) 0.78
Photochemotherapy and photodynamic toxicity: simple methods for identifying potentially active agents. Biochem Med (1977) 0.78
Hepatic excretion of circulating bilirubin photoproducts in the Gunn rat. J Clin Invest (1980) 0.78